All Videos

HF21 / 21 episodes / 21 minutes: CHFS Perspective and Case-Based Approach on the 2021 CHFS/CCS HF Guidelines

September 9, 2021

Top 3 Conundrums in HF: Worsening Heart Failure (7:00-8:00 pm ET)

September 21, 2021

CAN-R³ : Initiative canadienne pour la réduction du risque résiduel : Nouveautés dans la prise en charge de la dyslipidémie

September 23, 2021

HF21 series / 21 episodes / 21 minutes: Beyond Foundational Therapy: When to Reach in the Tool Box

September 27, 2021

HF21 series / 21 episodes / 21 minutes: Recommendations for Initiation of SGLT2i in Patients with HF and T2D

September 29, 2021

Underestimated: Assessing CV Risk in Female Patients and Residual Risk in Patients with CAD

September 30, 2021

HF21 series / 21 episodes / 21 minutes: Is it Time for Device Implementation yet?

October 4, 2021

L’ensemble d’ordonnances de la SCIC/SQIC pour les admissions liées à l’insuffisance cardiaque

October 4, 2021

HF21 series / 21 episodes / 21 minutes: Is There a Right Way and a Wrong Way? Sequencing of Foundational Therapy in HFrEF

October 5, 2021

Is Colchicine the Third Pillar of Secondary Prevention of ASCVD?

October 5, 2021

La colchicine est-elle le troisième pilier de la prévention secondaire de la MCVA ?

October 27, 2021

Is Colchicine the Third Pillar of Secondary Prevention of ASCVD?

October 28, 2021

2021 CHFS Heart Failure Admission Order Set Update

November 25, 2021

Is Colchicine the Third Pillar of Secondary Prevention of ASCVD?

November 30, 2021

Closing the Gap with Novel and Emerging Therapies

September 14, 2021

Contemporary Lipid Management for Secondary Prevention of ASCVD: Statin Intolerance, Familial Hypercholesterolemia, and Women

September 2, 2021

Top 3 Conundrums in HF: Hyperkalemia and Chronic Kidney Disease

August 31, 2021

Current Dyslipidemia Management in Canada: What do the 2021 guidelines say?

Conférence Virtuelle Canadienne sur l'hyperkaliémie dans l'insuffisance cardiaque

Virtual Canadian Speaker Tour: Hyperkalemia management in Heart Failure

Breaking News: A Canadian perspective from AHA 2020

December 10, 2020

Colchicine: Emerging Data and Impact on Clinical Practice

October 7, 2020

Colchicine: Une idée, des données probantes, un changement de pratique

September 30, 2020

Quelles sont les considerations de traiter la coronopathie au-delà de l’AAS? Est-ce le temps d’établir un nouveau standard?

September 29, 2020

Le Nez Seul Le Sait: Optimisation de la prise en charge de la rhinite allergique

September 25, 2020

The Nose Knows: Optimizing Allergic Rhinitis Management

September 24, 2020

Les NACO chez les patients âgés et vulnérables : Que devrions-nous savoir?

September 15, 2020

Managing the Elderly, Frail and Renal AF Patient: What we need to know

Dispelling Misperceptions in AF: Managing the challenges of renally impaired patients

Outils et technologies utiles en télémédecine pour le diagnostic et le suivi des patients avec FA durant la pandémie de COVID-19

Quelles sont les considerations de traiter la coronopathie au-delà de l'AAS? Est-ce le temps d'établir un nouveau standard?

Dispelling myths in AF: Managing the challenges of elderly, frail and/or renally impaired patients

An Approach to the Treatment of AF and CV Disease in These Challenging Times

How to Reduce the Risk of Major Cardiovascular and Limb Events in the CAD + PAD Patients

Prise en charge virtuelle des patients atteints de maladies cardiovasculaires pendant la pandémie de COVID

Hot Topics in Vascular Protection for the CAD Patient and AF Patient

Virtual Management of Patients with AF and CV Disease During the COVID Pandemic

Breaking News: A Canadian perspective from ACC 2020

How to Manage the Risks of CV Events and Limb Events of the CAD+PAD Patient

How to Manage the Risks of CV Events and Limb Events of the CAD+PAD Patient

Les NACO chez les patients âgés et vulnérables : Que devrions-nous savoir?

February 13, 2020

Optimizing Heart Failure Therapy - The Time is Now: Putting Evidence into Practice

December 5, 2019

Deconstructing Cardiovascular Outcomes for Patients with Diabetes

December 5, 2019

Diabetes Mobile Apps: Benefits for Patients and Healthcare Professionals

November 13, 2019

The Evolving Landscape of Cutaneous Squamous Cell Carcinoma Treatment: Updates on Immunotherapy Treatment

October 30, 2019

15 min. Highlights from The Great Debate: Aspirin, DAPT or dual pathway inhibition for secondary prevention in stable ASCVD patients?

October 26, 2019

Women and CV Disease: Closing Care Gaps & Assessing Risk